Skip to content
healthcare.dev

Lacosamide

NDC 53746-926, Lacosamide, tablet, from Amneal Pharmaceuticals of New York LLC.

Product NDC
53746-926
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204857
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53746-926 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE200 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
53746-926-0553746092605500 TABLET in 1 BOTTLE (53746-926-05)
53746-926-605374609266060 TABLET in 1 BOTTLE (53746-926-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0e21389b-2f51-4975-aa21-fc5c9dd9f6dc

Use it

Look up 53746-926 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53746-926 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53746-926. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.